ArticleCardiovascular diabetology2022

Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study.

Carlos King Ho Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.